SK4497A3 - Sulfonamide derivatives of azolones, method of producing, pharmaceutical composition on their base and their producing - Google Patents

Sulfonamide derivatives of azolones, method of producing, pharmaceutical composition on their base and their producing Download PDF

Info

Publication number
SK4497A3
SK4497A3 SK44-97A SK4497A SK4497A3 SK 4497 A3 SK4497 A3 SK 4497A3 SK 4497 A SK4497 A SK 4497A SK 4497 A3 SK4497 A3 SK 4497A3
Authority
SK
Slovakia
Prior art keywords
formula
pharmaceutically acceptable
compounds
alkyl
isomeric forms
Prior art date
Application number
SK44-97A
Other languages
English (en)
Slovak (sk)
Inventor
Jan Heeres
Raymond A Stokbroekx
Joseph H Mostmans
Der Veken Louis J E Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SK4497A3 publication Critical patent/SK4497A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Lubricants (AREA)
SK44-97A 1994-07-12 1995-07-05 Sulfonamide derivatives of azolones, method of producing, pharmaceutical composition on their base and their producing SK4497A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202015 1994-07-12
PCT/EP1995/002619 WO1996001818A1 (en) 1994-07-12 1995-07-05 Sulfonamide derivatives of azolones anti-helicobacter agents

Publications (1)

Publication Number Publication Date
SK4497A3 true SK4497A3 (en) 1997-12-10

Family

ID=8217029

Family Applications (1)

Application Number Title Priority Date Filing Date
SK44-97A SK4497A3 (en) 1994-07-12 1995-07-05 Sulfonamide derivatives of azolones, method of producing, pharmaceutical composition on their base and their producing

Country Status (21)

Country Link
US (2) US5571811A (cs)
EP (1) EP0770071B1 (cs)
JP (1) JPH10502386A (cs)
CN (1) CN1068878C (cs)
AT (1) ATE206706T1 (cs)
AU (1) AU684981B2 (cs)
BR (1) BR9508376A (cs)
CA (1) CA2194562A1 (cs)
CZ (1) CZ2997A3 (cs)
DE (1) DE69523159T2 (cs)
FI (1) FI970113L (cs)
HU (1) HUT76636A (cs)
IL (1) IL114537A (cs)
MX (1) MX9700340A (cs)
NO (1) NO970089L (cs)
NZ (1) NZ289853A (cs)
PL (1) PL318149A1 (cs)
SK (1) SK4497A3 (cs)
TW (1) TW341571B (cs)
WO (1) WO1996001818A1 (cs)
ZA (1) ZA955760B (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637592A (en) * 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones
DE60033019D1 (de) * 1999-03-17 2007-03-08 Morinaga & Co Arzneimittel, nahrungsmittel, getränke und futter enthaltend eine kakao-komponente
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
WO2004044188A1 (en) * 2002-11-14 2004-05-27 Intercytex Limited Cultivation of hair inductive cells
CA2517291C (en) * 2003-03-19 2012-05-08 Exelixis, Inc. Ortho-substituted aryl and heteroaryl tie-2 modulators and methods of use
EP2316458A1 (en) * 2004-09-20 2011-05-04 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
JP4958787B2 (ja) * 2004-09-20 2012-06-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトステアロイル−CoAデサチュラーゼを阻害するためのピリジン誘導体
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
EP1804799B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1799667B1 (en) 2004-09-20 2013-03-20 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
US7767677B2 (en) * 2004-09-20 2010-08-03 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CN101083986A (zh) * 2004-09-20 2007-12-05 泽农医药公司 双环杂环衍生物及其作为硬脂酰CoA去饱和酶(SCD)抑制剂的用途
CA2580856A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP2029138A1 (en) * 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
EP3906226A4 (en) * 2019-01-06 2023-03-15 Psomagen, Inc. HTRA INHIBITORS AND CAGA INHIBITORS AND THEIR USE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
CA2076257A1 (en) * 1991-09-13 1993-03-14 Jan Heeres 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones

Also Published As

Publication number Publication date
NZ289853A (en) 1997-11-24
US5728700A (en) 1998-03-17
FI970113A7 (fi) 1997-01-10
FI970113A0 (fi) 1997-01-10
PL318149A1 (en) 1997-05-12
MX9700340A (es) 1997-05-31
AU684981B2 (en) 1998-01-08
ATE206706T1 (de) 2001-10-15
US5571811A (en) 1996-11-05
EP0770071A1 (en) 1997-05-02
JPH10502386A (ja) 1998-03-03
TW341571B (en) 1998-10-01
NO970089D0 (no) 1997-01-09
EP0770071B1 (en) 2001-10-10
CZ2997A3 (en) 1997-09-17
CA2194562A1 (en) 1996-01-25
BR9508376A (pt) 1997-10-28
ZA955760B (en) 1997-01-13
CN1152308A (zh) 1997-06-18
CN1068878C (zh) 2001-07-25
HU9700080D0 (en) 1997-02-28
FI970113L (fi) 1997-01-10
AU2981995A (en) 1996-02-09
WO1996001818A1 (en) 1996-01-25
NO970089L (no) 1997-03-10
DE69523159T2 (de) 2002-06-20
HUT76636A (en) 1997-10-28
IL114537A (en) 1999-04-11
IL114537A0 (en) 1995-11-27
DE69523159D1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
AU684981B2 (en) Sulfonamide derivatives of azolones anti-helicobacter agents
US5639754A (en) Urea and thiourea derivatives of azolones
SK4397A3 (en) Acyl azolones, manufacturing process thereof, pharmauceutical compositions on their base and process for producing them
PL174836B1 (pl) Wykazujące działanie przeciwko bakteriom Helicobacter nowe podstawione pochodne azolonu i sposób wytwarzania podstawionych pochodnych azolonu
US5607932A (en) Heterocyclic derivatives of azolones
US5710156A (en) Ester and carbamate derivatives of azolones
CZ287159B6 (en) 4-Quinolyl derivatives per se and for use as medicaments, process of their preparation and pharmaceutical preparations based thereon
EP0770072A1 (en) Anti-helicobacter urea and thiourea derivatives of azolones
MXPA96004610A (en) Ester derivatives and anti-helicobac azolone carbamate